SCHEMBL6956983

SCHEMBL6956983

O=C(NCc1ccccc1)Oc1ccc2c(NCCCN3CCOCC3)noc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.52
▸ HTT P42858 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ AURKA O14965 1/20 0.46
▸ AURKB Q96GD4 1/20 0.46
▸ BCHE P06276 6/20 0.46
▸ ACHE P22303 5/20 0.46
▸ ACP1 P24666 1/20 0.44
▸ FAAH O00519 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ GAA P10253 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3505069 0.86 GAA (0.45) HTTACHEGAAKMT2ATDP1
SCHEMBL6951018 0.83 HRH3 (0.45) ACHEGAAKMT2ATDP1KDM4E
SCHEMBL6956988 0.81 ACHE (0.47) POLBHTTAURKAAURKBBCHE
SCHEMBL3504318 0.80 ACHE (0.41) ACHEMAPK1GAAKMT2ATDP1
SCHEMBL3504561 0.76 ALDH1A1 (0.46) MAPK1GAAKMT2ATDP1KDM4E
SCHEMBL3504380 0.75 ALDH1A1 (0.48) POLBHTTACP1TP53ALOX15
SCHEMBL6959886 0.75 ALDH1A1 (0.53) HTTHIF1ATP53ALOX15TSHR
SCHEMBL10132927 0.73 ABL1 (0.62) POLBAURKABCHEACHENPC1
SCHEMBL3503323 0.73 HSP90AA1 (0.45) HIF1AACHEMAPK1GAATDP1
SCHEMBL3508765 0.73 ALDH1A1 (0.43) POLBHTTHIF1AACP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0669920-B1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2003-02-12 — — EP disclosed
US-6046203-A USEFUL FOR THE TREATMENT OF VARIOUS MEMORY DYSFUNCTIONS CHARACTERIZED BY A DECREASED CHOLINERGIC FUNCTION SUCH AS ALZHEIMER'S DISEASE; ALSO INHIBIT MONOAMINE OXIDASE AND HENCE ARE USEFUL AS ANTIDEPRESSANTS AVENTIS PHARMACEUTICALS INC. (US) 2000-04-04 — — US disclosed
US-5580982-A ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1996-12-03 — — US disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US disclosed
Send feedback